Diagnosticos da America SA

BSP:DASA3 (Brazil)  
R$ 2.26 (+3.67%) Nov 29
On watch
At Loss
P/B:
0.20
Market Cap:
R$ 2.82B ($ 472.72M)
Enterprise V:
R$ 14.03B ($ 2.35B)
Volume:
1.32M
Avg Vol (2M):
795.29K
Warning! GuruFocus detected 6 Severe warning signs with DASA3. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
1.32M
Market Cap R$:
2.82B
Market Cap $:
472.72M
At Loss
Avg Vol (2M):
795.29K
Enterprise Value R$:
14.03B
Enterprise Value $:
2.35B
PB Ratio:
0.20
Alerts Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

Diagnosticos da America SA

ISIN : BRDASAACNOR1
https://www.dasa3.com.br/a-dasa/historico/
Avenida Jurua, 434, Alphaville, Barueri, SP, BRA, 06455-010
Compare
Compare
BSP:FLRY3BSP:AALR3TMODHRSHSE:603259IDXXIQVAXSWX:LONNMTDICLRILMNLHDGXWATXPAR:BIMEXASRVTYXPAR:ERFASX:SHL
Traded in other countries / regions
DASA3.BrazilDIAOF.USA
IPO Date
2004-11-19
Description
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).

Financial Strength

4/10
Name Current Vs Industry Vs History
Cash-To-Debt 0.2
Equity-to-Asset 0.31
Debt-to-Equity 1.63
Debt-to-EBITDA 6.33
Interest Coverage 0.72
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.78
Distress
Grey
Safe
Beneish M-Score -2.3
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

8/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 8.9
3-Year EBITDA Growth Rate 15.7
3-Year EPS without NRI Growth Rate -46.1
3-Year Book Growth Rate 10.1
Future 3-5Y Total Revenue Growth Rate 6.64

Momentum Rank

4/10
Name Current Vs Industry Vs History
5-Day RSI 43.85
9-Day RSI 42.24
14-Day RSI 40.66
6-1 Month Momentum % -26.76
12-1 Month Momentum % -71.62

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.65
Quick Ratio 1.57
Cash Ratio 0.49
Days Inventory 15.86
Days Sales Outstanding 110.12
Days Payable 45.45

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.8
Shareholder Yield % -4.46

Profitability Rank

6/10
Name Current Vs Industry Vs History
Gross Margin % 26.62
Operating Margin % 8
Net Margin % -6.05
FCF Margin % -5.38
ROE % -11.84
ROA % -3.31
ROIC % 6.03
ROC (Joel Greenblatt) % 10.69
ROCE % 4.19
Years of Profitability over Past 10-Year 6

GF Value Rank

2/10
Name Current Vs Industry Vs History
Forward PE Ratio 8.05
PS Ratio 0.11
PB Ratio 0.2
EV-to-EBIT 15.57
EV-to-Forward-EBIT 10.17
EV-to-EBITDA 6.33
EV-to-Forward-EBITDA 6.11
EV-to-Revenue 0.94
EV-to-Forward-Revenue 1.1
EV-to-FCF -17.42
Price-to-Projected-FCF 0.7
Price-to-Median-PS-Value 0.06
Earnings Yield (Greenblatt) % 6.42
FCF Yield % -28.51
Forward Rate of Return (Yacktman) % -20.03

Financials

BSP:DASA3's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Diagnosticos da America SA Executives

Details

GF Value: R$10.08

BSP:DASA3

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil R$) 14,971.106
EPS (TTM) (R$) -1.211
Beta 1.33
Volatility % 41.39
14-Day RSI 40.66
14-Day ATR (R$) 0.149612
20-Day SMA (R$) 2.376
12-1 Month Momentum % -71.62
52-Week Range (R$) 2.05 - 10.3
Shares Outstanding (Mil) 1,249.65

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Diagnosticos da America SA Filings

Filing Date Document Date Form
No Filing Data

Diagnosticos da America SA Stock Events

Financials Calendars
Event Date Price(R$)
No Event Data

Diagnosticos da America SA Frequently Asked Questions

What is Diagnosticos da America SA(BSP:DASA3)'s stock price today?
The current price of BSP:DASA3 is R$2.26. The 52 week high of BSP:DASA3 is R$10.30 and 52 week low is R$2.05.
When is next earnings date of Diagnosticos da America SA(BSP:DASA3)?
The next earnings date of Diagnosticos da America SA(BSP:DASA3) is .
Does Diagnosticos da America SA(BSP:DASA3) pay dividends? If so, how much?
Diagnosticos da America SA(BSP:DASA3) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.